Evans D, Hirasen K, Ramushu C, Long L, et al. Patient and provider costs of the new BPaL regimen for drug-resistant tuberculosis treatment in South Africa: A cost-effectiveness analysis. PLoS One 2024;19:e0309034.
PMID: 39432463